Semaglutide dosage for weight loss is measured in milligrams (mg), not milliliters (mL). The mL volume a prefilled pen delivers depends on the concentration of the formulation. This guide explains how mg translates into mL across FDA-approved Wegovy and Ozempic pen concentrations for educational reference. It is not prescriptive and should never be used to self-adjust therapy.
Why This Question Comes Up
Patients frequently search for mL-based dosing charts because compounded semaglutide from some telehealth and weight-loss clinics is supplied in vials that require drawing measured volumes into a syringe. FDA-approved pens like Wegovy and Ozempic hide the mL math: you dial the mg dose on the pen counter and the device delivers the correct volume automatically. With compounded vials, the patient or clinician measures mL directly, which is why understanding the conversion is a common concern.
Compounded semaglutide is only legal during documented FDA drug shortages and is subject to different safety and purity oversight than brand-name pens. See our guide on prediabetes and diabetes treatment options for a broader discussion.
How Wegovy Pens Work
Wegovy comes as single-dose pens, each labeled with one mg strength. You do not dial a dose and you do not measure mL. The pen injects its full volume automatically, delivering the mg amount printed on the package. The total liquid in each Wegovy pen is approximately 0.5 mL for lower doses and up to 0.75 mL for the highest. Volumes differ by strength because the manufacturer varies the concentration to keep the injection small.
Semaglutide Concentration and Volume Reference Chart
| Product | Concentration | Dose | Approximate Volume Delivered | Notes |
|---|---|---|---|---|
| Wegovy 0.25 mg pen | 0.5 mg/mL | 0.25 mg | 0.5 mL (auto) | Starting dose, weeks 1-4 |
| Wegovy 0.5 mg pen | 1 mg/mL | 0.5 mg | 0.5 mL (auto) | Weeks 5-8 |
| Wegovy 1 mg pen | 2 mg/mL | 1 mg | 0.5 mL (auto) | Weeks 9-12 |
| Wegovy 1.7 mg pen | 3.4 mg/mL | 1.7 mg | 0.5 mL (auto) | Weeks 13-16 |
| Wegovy 2.4 mg pen | 4.8 mg/mL | 2.4 mg | 0.5 mL (auto) | Maintenance dose |
| Ozempic 2 mg/1.5 mL pen | 1.34 mg/mL | 0.25 mg | ~0.19 mL (dial) | Diabetes starting dose |
| Ozempic 2 mg/1.5 mL pen | 1.34 mg/mL | 0.5 mg | ~0.37 mL (dial) | Diabetes titration |
| Ozempic 2 mg/1.5 mL pen | 1.34 mg/mL | 1 mg | ~0.74 mL (dial) | Diabetes maintenance |
| Ozempic 4 mg/3 mL pen | 1.34 mg/mL | 1 mg | ~0.74 mL (dial) | Same concentration, larger reservoir |
| Ozempic 8 mg/3 mL pen | 2.68 mg/mL | 2 mg | ~0.74 mL (dial) | Higher concentration for 2 mg dose |
The Wegovy Weight Loss Titration
Wegovy follows a 16-week dose-escalation schedule designed to minimize gastrointestinal side effects. Week 1-4: 0.25 mg weekly. Week 5-8: 0.5 mg weekly. Week 9-12: 1 mg weekly. Week 13-16: 1.7 mg weekly. Week 17 onward: 2.4 mg weekly maintenance. Each step allows the body to adjust to the effects on appetite and gastric emptying. Titration pace may be slowed by the prescribing clinician if side effects are significant.
The STEP-1 clinical trial, published in the New England Journal of Medicine (2021), demonstrated that adults without diabetes lost an average of 14.9% of body weight at 68 weeks on 2.4 mg weekly, compared with 2.4% on placebo.
Why Pen Concentrations Vary
Novo Nordisk designed Wegovy pens so each strength delivers roughly the same small injection volume (0.5-0.75 mL) by adjusting concentration. This keeps injections comfortable regardless of dose. Ozempic, approved for type 2 diabetes, uses multi-dose pens with a consistent concentration within a pen but different concentrations across pen generations. The newer 8 mg/3 mL Ozempic pen supports a 2 mg weekly diabetes dose without requiring a larger injection volume.
Compounded semaglutide pharmacies sometimes supply vials at 2.5 mg/mL, 5 mg/mL, or other custom concentrations. These require patients to understand the math before each injection, which is why working with a licensed prescriber who handles the calculation matters. Read more in our section on prediabetes overview and care.
Side Effects and Safety Reminders
Common adverse effects include nausea, vomiting, diarrhea, constipation, and abdominal pain, most frequent during titration. Rare but serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and a rodent-only signal for medullary thyroid tumors that prompts a boxed warning. Semaglutide is contraindicated in people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2.
The Bottom Line
A semaglutide dosage chart in mL is useful for understanding how prefilled pens work, but actual dosing decisions must come from your prescribing clinician. FDA-approved Wegovy pens deliver fixed mg doses in preset volumes automatically; Ozempic pens let you dial specific mg amounts, with the mL volume determined by pen concentration. Never self-adjust doses based on an online chart — talk to a licensed prescriber who can titrate safely based on your history and response.
